Blog
Follow us for the latest trends, insights and innovations in the pharmaceutical industry.
Payment Terms for Intermediates: 7 Buyer Mistakes to Avoid
This guide compares T/T, L/C, D/P and D/A for pharmaceutical intermediate purchases, with worked costs on a $60,000 order and the seven mistakes buyers make.
Read More →
Impurity Fate Mapping: 5 Documents Buyers Should Request
An impurity absent from a Certificate of Analysis is not necessarily absent from the process — it may simply have been purged downstream. This guide ...
Read More →
Dual Sourcing for API Intermediates: A Buyer’s Qualification Checklist
This checklist shows buyers how to qualify a second supplier in six steps — documentation, batch consistency, quality agreements, and activation triggers included.
Read More →
Custom Synthesis vs Catalog Intermediates: A Buyer’s Decision Framework
This article presents a buyer's decision framework built on six factors: specification match, lead time predictability, total cost of ownership, batch-to-batch consistency, documentation depth, and ...
Read More →




